603896.SS - Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

Shanghai - Shanghai Delayed price. Currency in CNY
Currency in CNY

Valuation measures4

Market cap (intra-day) 9.15B
Enterprise value 8.28B
Trailing P/E 31.29
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)10.59
Price/book (mrq)4.53
Enterprise value/revenue 9.95
Enterprise value/EBITDA 27.40

Trading information

Stock price history

Beta (5Y monthly) 0.44
52-week change 314.22%
S&P500 52-week change 32.72%
52-week high 358.66
52-week low 331.82
50-day moving average 346.72
200-day moving average 341.67

Share statistics

Avg vol (3-month) 33.78M
Avg vol (10-day) 33.23M
Shares outstanding 5197.21M
Implied shares outstanding 6N/A
Float 8109.12M
% held by insiders 148.37%
% held by institutions 18.82%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.44
Trailing annual dividend yield 30.97%
5-year average dividend yield 4N/A
Payout ratio 427.93%
Dividend date 3N/A
Ex-dividend date 426 May 2022
Last split factor 21.3:1
Last split date 326 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023


Profit margin 33.84%
Operating margin (ttm)28.38%

Management effectiveness

Return on assets (ttm)5.88%
Return on equity (ttm)15.36%

Income statement

Revenue (ttm)831.51M
Revenue per share (ttm)4.29
Quarterly revenue growth (yoy)1.20%
Gross profit (ttm)699.86M
EBITDA 291.05M
Net income avi to common (ttm)281.4M
Diluted EPS (ttm)1.46
Quarterly earnings growth (yoy)6.10%

Balance sheet

Total cash (mrq)1.65B
Total cash per share (mrq)8.39
Total debt (mrq)782.11M
Total debt/equity (mrq)39.62
Current ratio (mrq)3.70
Book value per share (mrq)10.01

Cash flow statement

Operating cash flow (ttm)338.74M
Levered free cash flow (ttm)-18.9M